Low-frequency Variation Near Common Germline Susceptibility Loci Are Associated with Risk of Ewing Sarcoma
Overview
Authors
Affiliations
Background: Ewing sarcoma (EwS) is a rare, aggressive solid tumor of childhood, adolescence and young adulthood associated with pathognomonic EWSR1-ETS fusion oncoproteins altering transcriptional regulation. Genome-wide association studies (GWAS) have identified 6 common germline susceptibility loci but have not investigated low-frequency inherited variants with minor allele frequencies below 5% due to limited genotyped cases of this rare tumor.
Methods: We investigated the contribution of rare and low-frequency variation to EwS susceptibility in the largest EwS genome-wide association study to date (733 EwS cases and 1,346 unaffected controls of European ancestry).
Results: We identified two low-frequency variants, rs112837127 and rs2296730, on chromosome 20 that were associated with EwS risk (OR = 0.186 and 2.038, respectively; P-value < 5×10-8) and located near previously reported common susceptibility loci. After adjusting for the most associated common variant at the locus, only rs112837127 remained a statistically significant independent signal (OR = 0.200, P-value = 5.84×10-8).
Conclusions: These findings suggest rare variation residing on common haplotypes are important contributors to EwS risk.
Impact: Motivate future targeted sequencing studies for a comprehensive evaluation of low-frequency and rare variation around common EwS susceptibility loci.
Re-envisioning genetic predisposition to childhood and adolescent cancers.
Kratz C Nat Rev Cancer. 2024; 25(2):109-128.
PMID: 39627375 DOI: 10.1038/s41568-024-00775-7.
Alba-Pavon P, Alana L, Gutierrez-Jimeno M, Garcia-Obregon S, Imizcoz T, Panizo E Sci Rep. 2023; 13(1):2959.
PMID: 36805510 PMC: 9941115. DOI: 10.1038/s41598-023-29982-2.
Lee O, Rodrigues C, Lin S, Luo W, Jones K, Brown D Am J Hum Genet. 2023; 110(3):427-441.
PMID: 36787739 PMC: 10027473. DOI: 10.1016/j.ajhg.2023.01.017.
Cidre-Aranaz F, Watson S, Amatruda J, Nakamura T, Delattre O, de Alava E Nat Rev Dis Primers. 2022; 8(1):66.
PMID: 36202860 DOI: 10.1038/s41572-022-00393-3.
Shulman D, Whittle S, Surdez D, Bailey K, de Alava E, Yustein J NPJ Precis Oncol. 2022; 6(1):65.
PMID: 36115869 PMC: 9482616. DOI: 10.1038/s41698-022-00307-2.